Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Ahmad Jalili, Anthony Bewley, Michael Sticherling & Linda Stein Gold. (2022) Short Term and Long-Term Efficacy of Calcipotriene/ Betamethasone Dipropionate Foam Combination. Clinical, Cosmetic and Investigational Dermatology 15, pages 809-814.
Read now
Read now
Gabriella Fabbrocini, Clara De Simone, Paolo Dapavo, Perigiorgio Malagoli, Alessandro Martella & Piergiacomo Calzavara-Pinton. (2022) Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice. Journal of Dermatological Treatment 33:5, pages 2425-2432.
Read now
Read now
Sascha Gerdes, Manuel Velasco, Jashin J. Wu, Mario Hubo & Karen A. Veverka. (2021) Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: a review of real-world evidence (RWE). Journal of Dermatological Treatment 32:8, pages 883-893.
Read now
Read now
Caitlin G. Purvis, Esther A. Balogh, Courtney E. Heron & Steven R. Feldman. (2021) Topical calcipotriol plus betamethasone dipropionate for the treatment of plaque psoriasis: a drug evaluation. Expert Opinion on Pharmacotherapy 22:9, pages 1107-1118.
Read now
Read now
Matteo Megna, Eleonora Cinelli, Elisa Camela & Gabriella Fabbrocini. (2020) Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data. Expert Review of Clinical Immunology 16:6, pages 599-620.
Read now
Read now
Victoria Amat-Samaranch & Lluís Puig. (2020) Safety of calcipotriene and betamethasone dipropionate foam for the treatment of psoriasis. Expert Opinion on Drug Safety 19:4, pages 423-432.
Read now
Read now
Deeti J. Pithadia, Kelly A. Reynolds, Erica B. Lee & Jashin J. Wu. (2020) Psoriasis-associated itch: etiology, assessment, impact, and management. Journal of Dermatological Treatment 31:1, pages 18-26.
Read now
Read now
Articles from other publishers (7)
Yi‐Li Hou & Shang‐Hung Lin. (2023) Real‐world efficacy of adjunctive calcipotriene/betamethasone dipropionate foam for recalcitrant psoriatic lesions on the scalp or lower legs with biologic therapy. The Journal of Dermatology.
Crossref
Crossref
Laurent Misery, Jessica Gonnet, Nadine Mackenzie, Nathalie Beneton & Bruno Halioua. (2022) Real‐life self‐assessment of pruritus relief with a combination of calcipotriol/betamethasone dipropionate foam in patients with plaque psoriasis. JEADV Clinical Practice 1:4, pages 317-325.
Crossref
Crossref
Dimitrios Rigopoulos, Elisavet Lazaridou, Evangelia Papadavid, Sophia Georgiou, Vasiliki Chasapi, Konstantinos Sfaelos, George Cheliotis & Dimitrios Ioannides. (2022) Sub‐population analysis of patients with plaque psoriasis treated with calcipotriol/betamethasone aerosol foam; effectiveness and patient satisfaction, according to baseline disease severity and prior psoriasis treatment experience, in a Greek population. Dermatologic Therapy 35:6.
Crossref
Crossref
A. Armstrong & S. Gerdes. (2021) Calcipotriol/betamethasone dipropionate foam demonstrates comparable efficacy to clinical trial data in the real world, improves patient satisfaction and is cost‐effective. Journal of the European Academy of Dermatology and Venereology 35:S1, pages 28-34.
Crossref
Crossref
Gabriella Fabbrocini, Esteban Dauden, Ahmad Jalili & Anthony Bewley. (2020) Calcipotriol/betamethasone dipropionate aerosol foam in the treatment of psoriasis: new perspectives for the use of an innovative topical treatment from real-life experience. Giornale Italiano di Dermatologia e Venereologia 155:2.
Crossref
Crossref
Enrica Menditto, Valentina Orlando, Giuseppe De Rosa, Paola Minghetti, Umberto Musazzi, Caitriona Cahir, Marta Kurczewska-Michalak, Przemysław Kardas, Elísio Costa, José Sousa Lobo & Isabel Almeida. (2020) Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence. Pharmaceutics 12:1, pages 44.
Crossref
Crossref
. (2019) Betamethasone-dipropionate/calcipotriol. Reactions Weekly 1761:1, pages 81-81.
Crossref
Crossref